Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Budesonide Extended-release Tablets, 9 mg.
from The Medical News http://ift.tt/1DRVFVv
from The Medical News http://ift.tt/1DRVFVv
No comments:
Post a Comment